Amino Acid ·Moderate evidence ·Reviewed May 2026
Acetylated form of L-carnitine that crosses the blood-brain barrier for cognitive support.
The bottom line
Evidence rating moderate. Most-documented uses: cognitive function, neuroprotection, energy. 16 sources indexed (2003–2024), with 7 interaction records on file.
Core mechanism
Crosses BBB and donates acetyl groups for acetylcholine synthesis. Supports mitochondrial function in neurons and enhances nerve growth factor activity.13,1
Better absorbed on empty stomach for cognitive benefits2,4
Dosing protocol
Earlier-day dosing is usually preferred because it can feel energizing.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Acetyl-L-Carnitine HCl.
Assumes 500-1,000 mg/day from goal dosage. Vendor basis: BulkSupplements powder, NOW/iHerb, Vitacost, and Amazon marketplace capsules. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Foods provide L-carnitine rather than acetyl-L-carnitine, so this is only a rough carnitine-based comparison.
Timing: Morning
Can feel energizing, so earlier dosing is usually better.
Timing: Split twice daily
Most useful when nerve pain or low-energy symptoms are part of the picture.
Dose: 500-1,500 mg daily14
Timing: Morning or pre-lunch
Reserve bedtime use for people who do not find it activating.
What to test, the optimal window inside the conventional range, and how long a response takes.
Acetyl-L-carnitine (500 to 2000 mg per day) raises serum carnitine and is the form best studied for cognition and diabetic neuropathy.1,2
Same panel as L-carnitine. Track TMAO if cardiovascular risk is a concern.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Acetyl-L-Carnitine helps shuttle fatty acids into mitochondria for energy and may modestly improve mental and physical fatigue in some studies, though results are mixed.9,10
Use under clinician-guided pacing and rule out treatable causes of fatigue; view as supportive only.
Acetyl-L-carnitine supports mitochondrial energy and nerve growth factor signaling, with trial evidence for reduced pain in diabetic and chemotherapy-related neuropathy.3,5
Benefit develops over months; avoid in those with seizure disorders without clinician input.
Supports mitochondrial energy metabolism and is commonly used when low mental energy overlaps with fatigue.14,13
Take earlier in the day if it feels activating.
Supports mitochondrial fatty acid oxidation; evidence for chronic fatigue syndrome is modest.13
Take earlier in the day if activating.
Acetyl-L-carnitine supports mitochondrial fatty acid oxidation and cholinergic signaling, with emerging evidence for reducing fatigue and depressive symptoms.13,1
Some benefit is seen in older adults and in depression; it can be activating, so dose earlier in the day.
Acetyl-L-Carnitine supports mitochondrial energy and nerve function, and limited trials report some improvement in pain and mood in fibromyalgia.13,14
Evidence base is small; view as a supportive adjunct under medical guidance.
The acetylated form crosses into mitochondria and the brain to support fatty acid oxidation and energy metabolism, with limited direct weight-loss data.8,14
More studied for cognitive and energy support than weight loss, and best taken earlier in the day to avoid sleep disruption.
Acetyl-L-Carnitine aids mitochondrial fatty acid transport and may theoretically support energy and mental clarity during post-viral fatigue.
Direct long COVID evidence is limited; treat as a supportive adjunct, pace your activity, and follow up with your clinician.
Supports mitochondrial and nerve function and is used in neuropathy-oriented stacks.13,9
Earlier-day dosing is often best.
Supports mitochondrial function in neurons; small evidence for cognitive performance in older adults.13,7
Most relevant in age-related cognitive complaints.
Supports mitochondrial function and nerve repair, with some early interest in taxane neuropathy.3,5
Important: a trial suggested it may worsen taxane neuropathy, so this should only be considered with explicit oncologist approval.
Supports nerve mitochondrial function and regeneration, a plausible mechanism for chronic neuropathic pain repair.9,10
Adjunctive and mechanistic for this specific condition; benefits, if any, accrue slowly over months and should not delay proven medical treatments.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
Acetyl-L-Carnitine contributes to the body's carnitine pool, which supports the carnitine shuttle that moves long-chain fatty acids into the mitochondria for beta oxidation, a fuel pathway feeding the electron transport chain. It crosses the blood brain barrier, and trials in older adults and fatigue states suggest a possible benefit on perceived energy, though effect sizes are modest and variable.1,2
Acetyl-L-Carnitine contributes to the transport of fatty acids into mitochondria for energy production and has been studied for fatigue in older adults and some post-viral states. Long COVID evidence is preliminary, so it is positioned as an optional, supportive option for energy and mental clarity.1,2
Acetyl-L-Carnitine contributes to the carnitine pool that transports fatty acids into mitochondria for beta-oxidation and can cross into the brain, and some trials in older adults or people reporting fatigue suggest reduced mental and physical tiredness. Evidence is moderate and strongest in older or clinically fatigued groups rather than healthy young adults.1,2
Acetyl-L-Carnitine has mixed but plausible evidence for neuropathic pain and nerve regeneration support. It is adjunctive and should be reviewed if taking thyroid or anticoagulant therapy.1,3
Acetyl-L-Carnitine is studied for pain and fatigue conditions and may support mitochondrial fatty acid transport. Fibromyalgia evidence is still emerging, so use it as a time-limited trial with symptom tracking.3,5
Pathogenic SLC22A5 variants cause primary carnitine deficiency, a medical condition where carnitine replacement is genotype-directed (PMID 22420015).
Recommendation: Do not use consumer carnitine dosing as a substitute for care of suspected or confirmed primary carnitine deficiency.
Genome-wide work links trimethylamine N-oxide biology to choline and L-carnitine metabolism, including FMO3-related pathways (PMID 24675659).
Recommendation: If trimethylaminuria, high TMAO concern, or strong cardiovascular risk is present, review carnitine use with a clinician.
Both support mitochondrial energy production through complementary mechanisms; combined use is common in cardiovascular and neurological contexts.
Recommendation: Take with morning fat-containing meal. Useful stack for fatigue and statin-related complaints.
Both improve mitochondrial function in aging models; the classic Hagen and Ames protocol pairs them for cellular energy support.
Recommendation: Combine for age-related fatigue or mitochondrial support. Standard doses: ALCAR 1 to 2 g, ALA 200 to 600 mg per day.
Acetyl-L-Carnitine and Alpha-GPC act on complementary halves of the same acetylcholine-synthesis pathway, so they are commonly combined in cognitive and focus stacks. Alpha-GPC supplies the choline substrate while Acetyl-L-Carnitine helps supply the acetyl/acetyl-CoA substrate, supporting greater neurotransmitter output than either provides individually. This is a favorable, additive-to-synergistic combination rather than a risk.
Recommendation: These can be taken together safely. A typical daytime nootropic pairing is 500 to 1000 mg Acetyl-L-Carnitine with 300 to 600 mg Alpha-GPC, taken in the morning or early afternoon (both can be mildly stimulating, so avoid late-evening dosing). Take with or without food per tolerance. No mandatory time separation is needed.
Acetyl-L-Carnitine and Iodine pull on thyroid physiology in opposing directions. Iodine is taken to supply substrate for thyroid hormone production, whereas Acetyl-L-Carnitine antagonizes thyroid hormone action at the cellular level by limiting T3 and T4 entry into the nucleus. The net effect can be a partial reduction in the functional thyroid response the iodine is meant to support. In hyperthyroid states, by contrast, this same antagonism may be used intentionally and under supervision.
Recommendation: For most people taking modest Iodine for general nutritional support, this is a mild theoretical concern. People with hypothyroidism, those actively supplementing Iodine to correct deficiency, or anyone on thyroid hormone replacement should be cautious with regular high-dose Acetyl-L-Carnitine and discuss it with their clinician. If both are used, monitor thyroid symptoms or labs (TSH, free T4) periodically. Conversely, in hyperthyroid states this antagonism may be intentional and supervised.
Combining L-Carnitine with Acetyl-L-Carnitine is largely redundant because they draw on and replenish the same carnitine pool. The main practical difference is that ALCAR crosses the blood-brain barrier more readily (favoring cognitive/neural use) while plain L-Carnitine is used more for peripheral fatty-acid oxidation. Taking both is not harmful, but the doses count toward one cumulative carnitine intake rather than two, which matters for total-dose and TMAO considerations.
Recommendation: Usually pick the form that matches your goal rather than stacking: L-Carnitine (1,000 to 2,000 mg/day) for energy/exercise/peripheral metabolism, or Acetyl-L-Carnitine (500 to 2,000 mg/day) for cognitive support. If you do use both, count the combined amount as your total carnitine dose (aim to keep the total in a sensible range, commonly under about 2 to 3 g/day) rather than dosing each separately at full strength. No timing separation is needed.
Acetyl-L-carnitine supports fatty-acid oxidation and mitochondrial function in cardiac muscle. Carvedilol partially inhibits mitochondrial Complex I, so ALCAR's bioenergetic support may help offset this effect, especially in heart failure or ischemic cardiomyopathy.
Recommendation: Acetyl-L-carnitine 500-1500 mg/day is generally compatible with carvedilol and may add cardiac benefit. Discuss with your cardiologist before starting, especially if you have heart failure.
Acetyl-L-carnitine supports cardiac mitochondrial function and modestly lowers diastolic blood pressure. Combined with metoprolol in heart failure or ischemic heart disease, ALCAR may add cardioprotective benefit with minimal interaction risk.
Recommendation: Acetyl-L-carnitine 500-1500 mg/day is generally compatible with metoprolol. Discuss with your cardiologist before adding, especially if you have heart failure, and monitor blood pressure when starting.
Numbered references. Citations throughout the page link here.
WFSBP/CANMAT guidelines found moderate evidence supporting acetyl-L-carnitine for depression, with recommendations for its use as an adjunctive treatment.
L-carnitine/acetyl-L-carnitine supplementation significantly improved sperm motility (progressive motility and total motility) in men with idiopathic asthenozoospermia.
Di Stefano G, Di Lionardo A, Galosi E et al.. Acetyl-L-carnitine in painful peripheral neuropathy: a systematic review. Journal of pain research. 2019
Meta-analysis of 12 RCTs (791 participants) found ALC superior to placebo for depression; equally effective as fluoxetine and amisulpride for dysthymic disorder with fewer side effects.
ALC significantly reduced VAS pain scores in peripheral neuropathy patients; appeared more effective in diabetic vs non-diabetic neuropathy. Safe and well tolerated.
Meta-analysis showed significant advantage for ALCAR vs placebo in MCI and mild AD (effect size 0.201, 95% CI 0.107-0.295); benefit seen at 3 months and increased over time.
Malaguarnera G, Catania VE, Bertino G et al.. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial. Current pharmaceutical design. 2022
Curran MWT, Morhart MJ, Olson JL et al.. Acetyl-L-Carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome: A Double-Blind, Randomized, Controlled Trial. Plastic and reconstructive surgery. 2019
Curran MW, Olson J, Morhart M et al.. Acetyl-L-carnitine (ALCAR) to enhance nerve regeneration in carpal tunnel syndrome: study protocol for a randomized, placebo-controlled trial. Trials. 2016
ALC treatment is efficacious in alleviating pain symptoms, improves nerve fiber regeneration and vibration perception in patients with established diabetic neuropathy.
Aldendail CF, Chen P, Dibble HS et al.. A Comprehensive Review of Safety, Efficacy, and Indications for the Use of Alpha-Lipoic Acid and Acetyl-L-Carnitine in Neuropathic Pain. Integrative medicine (Encinitas, Calif.). 2024
ALC crosses BBB and donates acetyl groups for acetylcholine synthesis; supports mitochondrial function in neurons, enhances nerve growth factor activity, and exerts neurotrophic effects.
ALCAR supplementation increased brain noradrenaline and serotonin levels, consistent with its potential efficacy for depressive symptoms and mood support.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack